MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 107 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $200 | -44.3% | 99,078 | +24.0% | 0.00% | – |
Q1 2024 | $359 | +106.3% | 79,932 | +6.6% | 0.00% | – |
Q4 2023 | $174 | +56.8% | 74,970 | -13.9% | 0.00% | – |
Q3 2023 | $111 | -71.8% | 87,113 | -27.0% | 0.00% | – |
Q2 2023 | $394 | -21.2% | 119,345 | -1.7% | 0.00% | – |
Q1 2023 | $500 | -29.3% | 121,377 | +0.7% | 0.00% | – |
Q4 2022 | $707 | -99.9% | 120,519 | +7.6% | 0.00% | – |
Q3 2022 | $758,000 | +17.3% | 112,039 | -19.9% | 0.00% | – |
Q2 2022 | $646,000 | +17.2% | 139,819 | +1.3% | 0.00% | – |
Q1 2022 | $551,000 | -22.6% | 138,034 | +20.6% | 0.00% | – |
Q4 2021 | $712,000 | -92.3% | 114,447 | -88.3% | 0.00% | -100.0% |
Q3 2021 | $9,250,000 | -70.6% | 980,896 | -57.7% | 0.00% | -66.7% |
Q2 2021 | $31,475,000 | -34.6% | 2,317,747 | -22.1% | 0.00% | -40.0% |
Q1 2021 | $48,121,000 | -45.3% | 2,974,087 | -10.0% | 0.01% | -44.4% |
Q4 2020 | $87,929,000 | +158.2% | 3,304,346 | +80.7% | 0.01% | +125.0% |
Q3 2020 | $34,049,000 | +95.3% | 1,828,619 | +145.4% | 0.00% | +100.0% |
Q2 2020 | $17,438,000 | – | 745,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |